Shangzhi Liu

机构：Hubei University of Chinese Medicine

发表论文 6 篇 · 总被引 131 次 · h-index 2

代表论文

• Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model (2024 · Phytomedicine · 被引 89)
• Rg1 improves Alzheimer's disease by regulating mitochondrial dynamics mediated by the AMPK/Drp1 signaling pathway (2024 · Journal of Ethnopharmacology · 被引 37)
• Accurate Localization of Solar Modules in Utility-Scale Photovoltaic Plants Using Drone-Mounted Thermal Cameras (2025 · IEEE Transactions on Instrumentation and Measurement · 被引 1)
• Ditan Decoction alleviates glutamate excitotoxicity in an Aβ-induced Alzheimer's disease-like model through the regulation of ERBB2/PI3K/AKT signaling pathway (2026 · Journal of Ethnopharmacology)
• Corrigendum to “Rg1 improves Alzheimer's disease by regulating mitochondrial dynamics mediated by the AMPK/Drp1 signaling pathway” [J. Ethnopharmacol. 340 (2025) 119285] (2026 · Journal of Ethnopharmacology)
• Corrigendum to “Rg1 improves Alzheimer's disease by regulating mitochondrial dynamics mediated by the AMPK/Drp1 signaling pathway” [J. Ethnopharmacol. 340 (2025) 119285] (2025 · Journal of Ethnopharmacology)